"NANODIATER" - AN EURONANOMED ERA-NET PROJECT
News:
Nanodiater: "Nanoparticles designed to target chemokine-related inflammatory processes in vascular diseases and cancer metastasis and implementation of a biosensor to diagnose these disorders"
NANODIATER is a project proposed by an European Consortium of 7 Partners from 4 different countries, who's main objectives are:
1. To develop targeted therapies for inflammatory-related cardiovascular diseases (CVD) and tumour cell metastasis employing specially designed nanoparticles (NP) to release chemokines inhibitors restrictively at sites of activated endothelium.
2. To design and develop a NP-derived diagnostic kit (“Cell Sensor”) for non-invasive detection of blood circulating inflammatory cells or metastatic tumour cells can be predictors for the evolution of CVD or cancer, respectively.
Copyright 2011 Institute of Cellular Biology and Pathology "Nicolae Simionescu" All rights reserved. Design by Viorel Simion
